Board member Dr. Mette Kalager Publishes Editorial on Breast Cancer Screening in BMJ
In a December 6, 2017 editorial on Breast cancer screening in The BMJ, Frontier Science board member and Associate Professor at University of Oslo Clinical Effectiveness Research Group, Dr. Mette Kalager, looks at studies analyzing data on breast cancer mortality, mammography screening, and over-diagnosis, and references a new study in the same edition at BMJ, Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ 2017;359:j5224.
Dr. Kalager writes, “If most or all of the benefit is related to peripheral elements of mammography screening, such as rigorous quality assurance and improved patient care, then it is time to focus on those parts of the screening package and to reconsider the use of mammograms.”